Atossa Therapeutics Inc (ATOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,835 | 7,273 | 2,789 | 3,745 | 1,222 |
| Receivables | 396 | 358 | 4 | 3 | N/A |
| Other current assets | 9 | 16 | 0 | 0 | 0 |
| TOTAL | $5,735 | $7,898 | $2,950 | $3,976 | $1,517 |
| Non-Current Assets | |||||
| PPE Net | 60 | 12 | 14 | 19 | 28 |
| Intangibles | 71 | 76 | 561 | 586 | 610 |
| Other Non-Current Assets | 115 | 179 | 109 | 129 | 149 |
| TOTAL | $245 | $266 | $685 | $733 | $786 |
| Total Assets | $5,980 | $8,164 | $3,635 | $4,709 | $2,303 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 168 | 335 | 380 | 496 | 387 |
| Accrued Expenses | 173 | 90 | 51 | 44 | 35 |
| Other current liabilities | 380 | 800 | 641 | 1,366 | 353 |
| TOTAL | $721 | $1,225 | $1,072 | $1,906 | $775 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $721 | $1,225 | $1,072 | $1,906 | $775 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,652 | 2,651 | 2,209 | 975 | 617 |
| Common Shares | 477 | 477 | 210 | 151 | 57 |
| Retained earnings | -67,301 | -65,426 | -63,433 | -61,249 | -59,007 |
| TOTAL | $5,260 | $6,939 | $2,563 | $2,804 | $1,528 |
| Total Liabilities And Equity | $5,980 | $8,164 | $3,635 | $4,709 | $2,303 |